Ewing’s U: Dr. Matteo Trucco: New METTSEO Clinical Trial for Metastatic Ewing Sarcoma

Ewing's U
Written By Alana Arens

Dr. Matteo Trucco (Cleveland Clinic) discusses a new upfront trial for Metastatic Ewing sarcoma. METTSEO (Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes) will test the ability to administer frequently changing chemotherapy regimens, based on evolutionary biology principles called sequential second strikes, to patients with widely metastatic Ewing sarcoma in order to stop development of resistance to chemotherapy and improve cure rates. Link here.

Alana Arens
Previous

Ewing's U: Dr. Rashmi Chugh: Phase 1 INBRX-109 Trial
Next

GRANT: Aptadel Therapeutics (España) - $500,000